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Abstract
Objective and design It has been demonstrated that
changes in the normal-appearing white matter (NAWM) in
multiple sclerosis precede the appearance of classical
lesions. The understanding of NAWM biology in an
established disease model might help to clarify why some
of them progress to active demyelinating lesions.
Material or subjects C57BL6 male mice (19–21 g) were
used in this study.
Treatment Demyelination was induced by feeding mice a
diet containing 0.2% cuprizone for up to 5 weeks.
Methods Routine stainings (luxol fast blue, and hema-
toxylin and eosin) and immunohistochemistry were
performed to assess myelin status and the inﬂammatory
inﬁltrate.
Results We demonstrated that, in the toxic demyelination
cuprizone model, the corpus callosum is severely demye-
linated after a 5-week cuprizone challenge (acute
demyelination) whereas the ﬁmbria of the hippocampus
appear normal in routine myelin stainings. Microgliosis but
not astrogliosis is evident after acute demyelination in the
ﬁmbria. Interestingly, both regions, the ﬁmbria and the
corpus callosum, demonstrated early oligodendrocyte
apoptosis as well as intense microglia accumulation and
activation. However, only the corpus callosum progresses
to actively demyelination lesions whereas the ﬁmbria does
not.
Conclusions The applied model appears suitable for
elucidating pathways which promote progression of
affected tissue to an active lesion.
Keywords CNS inﬂammation  Inﬂammatory models
Introduction
Multiple sclerosis (MS) is the most common neurological
disorder in young adults in the Western world. In addition
to the well-characterized inﬂammatory white matter, his-
topathological and imaging studies have suggested that the
so-called ‘normal-appearing white matter’ (NAWM) has
signiﬁcant abnormalities [1]. Axonal injury, blood–brain
barrier changes and reactive astro- and microgliosis have
been reported at the histological level [2–4]. Little is
known about the molecular changes taking place in the
NAWM in MS. It has recently be suggested that NAWM in
MS is in a subtle balance between inﬂammation and neu-
roprotection [5]. Therefore, one might expect that the
understanding of molecular changes within the NAWM
could be exploited to develop new treatments.
In this study, we used the well-characterized toxic
cuprizone model. Cuprizone ingestion in mice induces a
highly reproducible demyelination of distinct brain regions,
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123such as the corpus callosum (CC) [6]. Some regions,
however, appear to be resistant to the toxin challenge, e.g.
the ﬁmbria of the hippocampus [7]. The aim of the study
was (1) to deﬁne whether the ﬁmbria fulﬁls histological
criteria of the NAWM in an established disease model and
(2) to get a better understanding of ‘NAWM-lesion’
development in this particular animal model.
Materials and methods
Research and animal care procedures were approved by the
Review Board for the Care of Animal Subjects of the
district government (North Rhine-Westphalia, Germany).
Demyelination was induced by feeding 8-week-old male
mice (C57BL/6; 19–21 g) a diet containing 0.2% cuprizone
(bis-cyclohexanone oxaldihydrazone; Sigma-Aldrich Inc.,
USA) mixed into a ground standard rodent chow for the
indicated periods. Tissue preparation and immunohisto-
chemistry (IHC) were performed as published in detail
previously [7, 8]. Anti-proteolipid protein (PLP) antibodies
(mouse IgG, 1:500; Serotec, Germany) were used to detect
myelin, anti-Iba1 antibodies (rabbit IgG, 1:250; Wako,
Germany) to detect microglia/macrophages, and anti-glial
ﬁbrillary acidic protein (GFAP) antibodies (rabbit IgG,
1:1,000; EnCor, USA) were used to visualize astrocytes.
Anti-olig2 antibodies (Millipore, Germany) were used to
detect oligodendrocytes.
Results
In a ﬁrst set of experiments, animals (n = 5 per experi-
mental group) were fed cuprizone for 5 weeks to induce
acute demyelination of the CC. Deﬁnite loss of PLP
immunoreactivity could be observed in the CC (Fig. 1b/e),
whereas other regions appeared unaffected, such as the
ﬁmbria of the hippocampus (Fig. 1c/f). Both regions
included in the subsequent study are indicated by the arrow
and star in Fig. 1d. Quantitative measurement of PLP
staining intensity conﬁrmed our observational results.
There was a signiﬁcant decrease in PLP staining intensity
in the CC (control 69.2 ± 6.8 [mean ± SEM] vs. 5 weeks
cuprizone 19.4 ± 4.4; P\0.005). This was not observed
in the ﬁmbria (control 65.3 ± 5.1 vs. 5 weeks cuprizone
61.0.4 ± 3.2; P = 0.49). Luxol fast blue staining showed
similar results (data not shown). To further investigate both
regions on the cellular level, we visualized microglia by
anti-Iba1 and (activated) astrocytes by anti-GFAP anti-
bodies, respectively. The quantiﬁcation of ﬁmbrial Iba1
?
and GFAP
? cell numbers after acute cuprizone-induced
demyelination is presented in Fig. 1u. Microglia were
uniformly distributed in the CC (Fig. 1g) and ﬁmbria
(Fig. 1i) of control animals while a sustained increase in
Iba1
? cell numbers was present in the demyelinated CC
(Fig. 1h) and, although to a lesser extend, in the ﬁmbria
(Fig. 1j). After 5 weeks cuprizone, higher numbers of
GFAP
? astrocytes compared to controls were seen within
the CC (Fig. 1k/l) but not in the ﬁmbria (Fig. 1m/n).
From our observation that deﬁnite microgliosis can be
observed within the ﬁmbrial region after acute cuprizone-
induced demyelination, we assumed that the ﬁmbria is
affected like the CC by the toxin per se, but does not
develop to a ‘classically’ demyelinated lesion. To test for
this hypothesis, animals (n = 6 per experimental group)
were fed cuprizone in a second experiment up to 5 weeks
and sacriﬁced on day 2, week 1, week 2 and week 5 after
the start of the cuprizone diet. Cells with morphological
characteristics typical for apoptosis such as condensed and/
or fragmented nuclei were seen at week 1 in both regions
included in the study (Fig. 1o/p). Control animals fed with
powdered food without cuprizone were lacking apoptotic
cells (data not shown). In a previous study, immunohisto-
chemistry for detection of CNPase conﬁrmed that these
apoptotic cells are oligodendrocytes [9]. Anti-Iba-1 IHC
revealed that pronounced microgliosis is evident in both
regions after week 1. In control animals, Iba1
? cells dis-
played a typical ramiﬁed morphology indicating a resting
state (Fig. 1q). At week 1 (Fig. 1s) and week 2 (Fig. 1t),
processes of microglia cells within the ﬁmbria appeared to
be retracted and cell bodies were swollen, which is fre-
quently associated with microglia activation [10].
Comparable morphological changes of microglia were
evident in the CC at weeks 1 and 2. While the magnitude of
microgliosis progressed in the CC until week 5 (Fig. 1h), a
reduction of microglia cell numbers could be observed in
the ﬁmbria. Only a moderate activation of ﬁmbrial astro-
cytes was detectable at week 2 (increased number and
swollen processes), whereas at all other time points in the
study, astrocytic cell parameters were the same as observed
in the ﬁmbria of control animals. Within the CC, astrocy-
tosis started at week 2; however, in contrast to the ﬁmbria,
it progressed in the CC until week 5. At week 2, the
number of olig2-positive cells was dramatically decreased
in the CC whereas no difference in oligodendrocyte cell
numbers (and PLP staining intensity) was evident in the
ﬁmbria compared to control animals.
Discussion
Activation of microglia is a well-known characteristic
histological feature of the NAWM in MS [2, 11]. Whether
activated microglia are beneﬁcial or detrimental for disease
progression is controversial [11, 12]. In this study, we have
shown that the ﬁmbria of the hippocampus, which shows
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induced demyelination, is not protected from the toxic
compound per se. Both regions, the ﬁmbria and the CC,
[13] demonstrated early oligodendrocyte apoptosis and
intense microglia accumulation and activation. However,
only in the CC did we observe lesions that progressed to
actively demyelination lesions, whereas such a course was
not seen in the ﬁmbria. Remyelination appears not to be the
underlying mechanism of preserved myelination in the
ﬁmbria, since at all time points in the study anti-PLP
staining intensity remained unchanged in this region.
It might be feasible that regional differences exist in
microglia function, as previously suggested [14]. We
assume that some intrinsic signaling contributes to a
‘switch’ from an anti-inﬂammatory to a pro-inﬂammatory
phenotype of microglia within the affected CC. The former
phenotype is also called ‘M1 or classically activated’, the
latter one ‘M2 or alternatively activated’ [13, 15]. Thera-
peutic bolstering of this apparent regulation could therefore
still be effective in halting the formation of new destructive
lesions in human MS. In this situation, prevention of fur-
ther damage rather than repair of existing damage could
still be achieved.
Summary
The applied animal model with an existing regional
diversity in the course of disease appears to be suitable for
elucidating pathways which promote progression of the
Fig. 1 Myelination and inﬂammatory cell composition in the medial
corpus callosum (CC) and ﬁmbrial region of the hippocampus. Anti-
PLP antibodies were used to visualize intact myelin in sections of
control and cuprizone-treated animals (a–f). Anti-Iba1 and anti-GFAP
antibodies were used to visualize microglia or astrocytes, respec-
tively. Arrowhead in (d) indicates the medial part of the CC, which is
shown in (b/e, g/h, k/l and o) in higher magniﬁcation. The star in
(d) indicates the ﬁmbrial region of the hippocampus, which is shown
in (c/f, i/j, m/n, p and q-t) in higher magniﬁcation. Pictures
(o/p) show hematoxylin-and-eosin-stained sections, illustrating apop-
totic oligodendrocytes (arrows) within the CC and ﬁmbria.
Quantiﬁcation of Iba1
? microglia and GFAP
? astrocytes (ﬁmbria)
in control and 5 weeks’ cuprizone-treated animals is given in (u).
***P\0.001; scale bars: 500 lm( a/d); 50 lm( b/c, e/f, g–n);
10 lm( o/p); 25 lm( q–t)
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123NAWM to an active lesion. We have focused on the ﬁ-
mbrial region of the hippocampus, since this brain region
can readily be dissected without the need of costly equip-
ment (such as laser-capture microscopy) for subsequent
analyses on the molecular level.
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